CONTRASTING EFFECTS OF LOVASTATIN AND CHOLESTYRAMINE ON LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND 24-HOUR URINARY MEVALONATE EXCRETION IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

被引：0

作者：

PAPPU, AS ^{[1
]}

ILLINGWORTH, DR ^{[1
]}

机构：

[1] OREGON HLTH SCI UNIV, DEPT MED, DIV ENDOCRINOL METAB & CLIN NUTR, L465, PORTLAND, OR 97201 USA

来源：

JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 1989年 / 114卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：554 / 562

页数：9

共 50 条

[31] EVINACUMAB MARKEDLY REDUCES LOW-DENSITY LIPOPROTEIN CHOLESTEROL IN ADOLESCENT PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA [J].

Reeskamp, L. F. ;

Greber-Platzer, S. ;

Saheb, S. ;

Stefanutti, C. ;

Stroes, E. S. G. ;

Ali, S. ;

Banerjee, P. ;

Pordy, R. ;

Zhao, J. ;

Raal, F. J. .

ATHEROSCLEROSIS, 2021, 331 :E49-E50

[32] Polymorphisms of the low-density lipoprotein receptor gene in Brazilian individuals with heterozygous familial hypercholesterolemia [J].

Salazar, LA ;

Cavalli, SA ;

Hirata, MH ;

Diament, J ;

Forti, N ;

Giannini, SD ;

Nakandakare, ER ;

Bertolami, MC ;

Hirata, RDC .

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2000, 33 (11) :1301-1304

[33] Low-density lipoprotein cholesterol bulk is the pivotal determinant of atherosclerosis in familial hypercholesterolemia [J].

Raal, FJ ;

Pilcher, GJ ;

Waisberg, R ;

Buthelezi, EP ;

Veller, MG ;

Joffe, BI .

AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (09) :1330-1333

[34] Effects of NK-104, a new hydroxymethylglutaryl-coenzyme reductase inhibitor, on low-density lipoprotein cholesterol in heterozygous familial hypercholesterolemia [J].

Kajinami, K ;

Koizumi, J ;

Ueda, K ;

Miyamoto, S ;

Takegoshi, T ;

Mabuchi, H .

AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (02) :178-183

[35] Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia [J].

Maugeais, C ;

Ouguerram, K ;

Frénais, R ;

Maugère, P ;

Charbonnel, B ;

Magot, T ;

Krempf, M .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1679-1686

[36] Ezetimibe significantly reduces low-density lipoprotein cholesterol in homozygous familial hypercholesterolemia [J].

Gagne, C ;

Gaudet, D ;

Bruckert, E ;

Ponsonnet, D ;

Lipka, L ;

LeBeaut, A ;

Suresh, R ;

Abreu, P ;

Veltri, E .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) :227A-227A

[37] Systematic Review of Low-Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia [J].

Wang, Anthony ;

Richhariya, Akshara ;

Gandra, Shravanthi R. ;

Calimlim, Brian ;

Kim, Lisa ;

Quek, Ruben G. W. ;

Nordyke, Robert J. ;

Toth, Peter P. .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (07)

[38] PLASMA-EXCHANGE AND LOW-DENSITY LIPOPROTEIN FILTRATION THERAPY IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA [J].

TIJHUIS, GJ ;

VANDOORMAAL, JJ ;

RIJSKAMP, L ;

SIBINGA, CTS ;

DOORENBOS, H .

PLASMA THERAPY & TRANSFUSION TECHNOLOGY, 1988, 9 (01) :29-34

[39] REDUCTION OF SERUM-CHOLESTEROL IN HETEROZYGOUS PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA - ADDITIVE EFFECTS OF COMPACTIN AND CHOLESTYRAMINE [J].

MABUCHI, H ;

SAKAI, T ;

SAKAI, Y ;

YOSHIMURA, A ;

WATANABE, A ;

WAKASUGI, T ;

KOIZUMI, J ;

TAKEDA, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (11) :609-613

[40] Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report [J].

Zenti, M. G. ;

Stefanutti, C. ;

Sanga, V. ;

Altomari, A. ;

Fabris, A. ;

Dauriz, M. ;

Bonora, E. .

JOURNAL OF CLINICAL APHERESIS, 2018, 33 (04) :546-550

← 1 2 3 4 5 →